Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jorge E. Cortes
New Tool for Monitoring Molecular Response in Chronic Myeloid Leukemia.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients <= 60 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Daily Palonosetron Is Superior to Ondansetron in the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients With Acute Myelogenous Leukemia
Cancer
Cancer Research
Oncology
Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin, and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Cancer
Cancer Research
Oncology
The Distribution of T-Cell Subsets and the Expression of Immune Checkpoint Receptors and Ligands in Patients With Newly Diagnosed and Relapsed Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
Epoetin Alpha Decreases the Number of Erythrocyte Transfusions in Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, and Burkitt Leukemia/Lymphoma
Cancer
Cancer Research
Oncology
Incidence, Outcomes, and Risk Factors of Pleural Effusion in Patients Receiving Dasatinib Therapy for Philadelphia Chromosome-Positive Leukemia
Haematologica
Hematology
Long-Term Efficacy and Safety of Dasatinib in Patients With Chronic Myeloid Leukemia in Accelerated Phase Who Are Resistant to or Intolerant of Imatinib
Blood Cancer Journal
Oncology
Hematology
Glasdegib in Combination With Cytarabine and Daunorubicin in Patients With AML or High-Risk MDS: Phase 2 Study Results
American Journal of Hematology
Hematology
Philadelphia Chromosome‐negative Acute Leukemia in Chronic Myeloid Leukemia
American Journal of Hematology
Hematology
1
2
3
›
